IRL-1620 Drug Record

  • IRL-1620 chembl:CHEMBL4298109

    Alternate Names:

    IRL-1620
    SPI-1620

    Drug Info:

    FDA Approval not approved
    Drug Class peptide
    Drug Indications adjuvant to chemotherapy
    (0 More Sources)

    Publications:

  • IRL-1620   EDNRB

    Interaction Score: 7.73

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name SPI-1620
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TTD

  • IRL-1620   EDNRA

    Interaction Score: 1.93

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name SPI-1620
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: SPI-1620

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications adjuvant to chemotherapy
    Drug Class peptide
    FDA Approval not approved

    Publications:

  • TTD: SPI-1620

    • Version: 2020.06.01

    Alternate Names:
    D07WYI TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL4298109

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: